Joanne Wuensch
Stock Analyst at Citi
(1.77)
# 3,060
Out of 5,028 analysts
1272
Total ratings
48.7%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterated: Buy | $125 | $100.10 | +24.88% | 89 | Oct 5, 2026 | |
| BAX Baxter International | Reiterated: Hold | $28 → $27 | $24.22 | +11.48% | 62 | Oct 5, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Buy | $208 | $180.67 | +15.13% | 41 | Oct 5, 2026 | |
| BLCO Bausch + Lomb | Rated: Buy | $21 | $17.17 | +22.31% | 19 | Oct 5, 2026 | |
| BSX Boston Scientific | Rated: Hold | $50 → $48 | $42.40 | +13.21% | 82 | Oct 5, 2026 | |
| DXCM DexCom | Reiterated: Buy | $105 | $86.90 | +20.83% | 66 | Oct 5, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $87.23 | +26.10% | 83 | Oct 5, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Hold | $75 → $71 | $65.74 | +8.00% | 28 | Oct 5, 2026 | |
| IART Integra LifeSciences Holdings | Reiterated: Hold | $19 → $15 | $13.29 | +12.87% | 31 | Oct 5, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $500 | $406.48 | +23.01% | 37 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 → $303 | $252.93 | +19.80% | 64 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $87.97 | +25.04% | 86 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $350 | $317.11 | +10.37% | 44 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $10 | $8.92 | +12.11% | 29 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $99 | $91.57 | +8.11% | 64 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 | $56.77 | +5.69% | 58 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $16.52 | +21.07% | 47 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $135.62 | - | 46 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $221.21 | +3.97% | 1 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 → $123 | $104.68 | +17.50% | 30 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $399 → $360 | $285.22 | +26.22% | 60 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $20.16 | +28.97% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $188 → $225 | $164.01 | +37.19% | 45 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $66.47 | +38.41% | 22 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $109.09 | +43.92% | 58 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $440.12 | +6.79% | 1 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $412 | $376.76 | +9.35% | 1 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 → $96 | $126.45 | -24.08% | 19 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.15 | $1.88 | n/a | 17 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 55.64 → CHF 57.30 | CHF 53.08 | n/a | 11 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $120 | $222.86 | n/a | 23 | Jan 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $27.41 | n/a | 2 | Sep 26, 2016 |
Abbott Laboratories
Oct 5, 2026
Reiterated: Buy
Price Target: $125
Current: $100.10
Upside: +24.88%
Baxter International
Oct 5, 2026
Reiterated: Hold
Price Target: $28 → $27
Current: $24.22
Upside: +11.48%
Becton, Dickinson and Company
Oct 5, 2026
Reiterated: Buy
Price Target: $208
Current: $180.67
Upside: +15.13%
Bausch + Lomb
Oct 5, 2026
Rated: Buy
Price Target: $21
Current: $17.17
Upside: +22.31%
Boston Scientific
Oct 5, 2026
Rated: Hold
Price Target: $50 → $48
Current: $42.40
Upside: +13.21%
DexCom
Oct 5, 2026
Reiterated: Buy
Price Target: $105
Current: $86.90
Upside: +20.83%
Edwards Lifesciences
Oct 5, 2026
Reiterated: Buy
Price Target: $110
Current: $87.23
Upside: +26.10%
GE HealthCare Technologies
Oct 5, 2026
Reiterated: Hold
Price Target: $75 → $71
Current: $65.74
Upside: +8.00%
Integra LifeSciences Holdings
Oct 5, 2026
Reiterated: Hold
Price Target: $19 → $15
Current: $13.29
Upside: +12.87%
Intuitive Surgical
Oct 5, 2026
Reiterated: Buy
Price Target: $500
Current: $406.48
Upside: +23.01%
Oct 5, 2026
Reiterated: Buy
Price Target: $298 → $303
Current: $252.93
Upside: +19.80%
Oct 5, 2026
Reiterated: Buy
Price Target: $110
Current: $87.97
Upside: +25.04%
Oct 5, 2026
Reiterated: Hold
Price Target: $350
Current: $317.11
Upside: +10.37%
Oct 5, 2026
Rated: Hold
Price Target: $8 → $10
Current: $8.92
Upside: +12.11%
Oct 5, 2026
Reiterated: Hold
Price Target: $99
Current: $91.57
Upside: +8.11%
Oct 2, 2026
Reiterated: Hold
Price Target: $60
Current: $56.77
Upside: +5.69%
Oct 1, 2026
Reiterated: Hold
Price Target: $24 → $20
Current: $16.52
Upside: +21.07%
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $135.62
Upside: -
Sep 21, 2026
Reiterated: Buy
Price Target: $230
Current: $221.21
Upside: +3.97%
Sep 18, 2026
Upgraded: Buy
Price Target: $92 → $123
Current: $104.68
Upside: +17.50%
Sep 10, 2026
Reiterated: Buy
Price Target: $399 → $360
Current: $285.22
Upside: +26.22%
Sep 2, 2026
Reiterated: Buy
Price Target: $26
Current: $20.16
Upside: +28.97%
Aug 14, 2026
Reiterated: Buy
Price Target: $188 → $225
Current: $164.01
Upside: +37.19%
Aug 13, 2026
Upgraded: Buy
Price Target: $92
Current: $66.47
Upside: +38.41%
Aug 13, 2026
Reiterated: Buy
Price Target: $157
Current: $109.09
Upside: +43.92%
Aug 10, 2026
Reiterated: Buy
Price Target: $470
Current: $440.12
Upside: +6.79%
Aug 3, 2026
Reiterated: Buy
Price Target: $412
Current: $376.76
Upside: +9.35%
Jul 8, 2026
Reiterated: Hold
Price Target: $92 → $96
Current: $126.45
Upside: -24.08%
May 23, 2025
Reiterated: Hold
Price Target: $4.15
Current: $1.88
Upside: n/a
Nov 16, 2022
Reiterated: Hold
Price Target: CHF 55.64 → CHF 57.30
Current: CHF 53.08
Upside: n/a
Jan 27, 2019
Reiterated: Buy
Price Target: $124 → $120
Current: $222.86
Upside: n/a
Sep 26, 2016
Reiterated: Buy
Price Target: $40
Current: $27.41
Upside: n/a